Prise en charge des thymomes chez l'homme : développement de cultures de cellules épithéliales dérivées de tumeurs pour la compréhension des dérégulations de la cellule tumorale

Prise en charge des thymomes chez l'homme : développement de cultures de cellules épithéliales dérivées de tumeurs pour la compréhension des dérégulations de la cellule tumorale

Les tumeurs épithéliales thymiques (TET) humaines sont rares (250 - 300 cas/an en France). On distingue les thymomes de type A, AB ou B d'évolution lente avec une survie actuarielle > 95% à 5 ans pour les stades précoces et les carcinomes thymiques d'évolution plus sévère avec une survi...

Full description

Bibliographic Details
Main Author:	Maury, Jean-Michel
Other Authors:	Lyon
Language:	fr
Published:	2019
Subjects:	Tumeurs thymiques Chirurgie Plèvre Cellules épithéliales thymiques tumorales Akt/ mTOR Rapamycine Prolifération cellulaire Thymic tumors Surgery Pleura Tumoral thymic epithelial cells Rapamycin Cell proliferation 570
Online Access:	http://www.theses.fr/2019LYSE1063/document

Similar Items

Découverte de cellules souches potentielles de l’épithélium thymique
by: Dumont-Lagacé, Maude
Published: (2015)

Tribbles Pseudokinase 3 Regulation and Contribution to Cancer
by: Bojana Stefanovska, et al.
Published: (2021-04-01)

Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells
by: Delphine Séhédic, et al.
Published: (2021-02-01)

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model
by: Wang Cun, et al.
Published: (2012-05-01)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
by: Henry Querfurth, et al.
Published: (2021-07-01)

Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway
by: Shangfeng Gao, et al.
Published: (2016-11-01)

Etude phénotypique des cellules endométriosiques profondes
by: Leconte, Mahaut
Published: (2012)

mTOR inhibition: a promise for a young heart.
by: Stêfany Bruno De Assis Cau, et al.
Published: (2012-02-01)

Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo
by: Linyan Zhou, et al.
Published: (2017-08-01)

Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics
by: Ming Q. Wei, et al.
Published: (2013-02-01)

Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration
by: Masoud Razmara, et al.
Published: (2018-10-01)

Rapamycin-Induced Apoptosis in HGF-Stimulated Lens Epithelial Cells by AKT/mTOR, ERK and JAK2/STAT3 Pathways
by: Fang Tian, et al.
Published: (2014-08-01)

Cellules souches, hormones sexuelles et régénération thymique
by: Dumont-Lagacé, Maude
Published: (2019)

The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling
by: Mee-Sup Yoon
Published: (2017-10-01)

Rapamycin Inhibits Expansion of Cord Blood Derived NK and T Cell
by: Monireh Zare, et al.
Published: (2017-09-01)

The mTOR Signalling Pathway in Human Cancer
by: Paula Soares, et al.
Published: (2012-02-01)

Genetics of tuberous sclerosis complex: implications for clinical practice
by: Caban C, et al.
Published: (2016-12-01)

The role of mammalian target of rapamycin (mTOR) in macrophage polarization
by: Byles, Vanessa A.
Published: (2016)

Prucalopride inhibits the glioma cells proliferation and induces autophagy via AKT-mTOR pathway
by: Hong Qiao, et al.
Published: (2018-06-01)

Oncogenic NanogP8 expression regulates cell proliferation and migration through the Akt/mTOR signaling pathway in human gastric cancer – SGC-7901cell line
by: Jiang Z, et al.
Published: (2016-08-01)

Immunohistochemical evidences showing the presence of thymulin containing cells located in involuted thymus and in peripheral lymphoid organs
by: Hugo Folch, et al.
Published: (2010-01-01)

Paradigmenwechsel in der Anti-Aging-Medizin: Hormesis, Target-of-Rapamycin-Komplex und erste Anti-Aging-Pillen // Paradigm Shift in Anti-Aging Medicine: Hormesis, Target of Rapamycin Complex and First Human Anti-Aging-Pills
by: Römmler A
Published: (2016-01-01)

Dose-dependent Effects of mTOR Inhibition on Weight and Mitochondrial Disease in Mice
by: Simon C Johnson, et al.
Published: (2015-07-01)

Antitumor Effects of Rapamycin in Pancreatic Cancer Cells by Inducing Apoptosis and Autophagy
by: Xi-Jing Wang, et al.
Published: (2012-12-01)

Metformin induces degradation of mTOR protein in breast cancer cells
by: Mohamed Alalem, et al.
Published: (2016-11-01)

Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
by: Luise Spormann, et al.
Published: (2020-07-01)

Combined Treatment with Doxorubicin and Rapamycin Is Effective against In Vitro and In Vivo Models of Human Glioblastoma
by: Anna Lisa Iorio, et al.
Published: (2019-03-01)

Inhibition of mTOR prevents ROS production initiated by ethidium bromide-induced mitochondrial DNA depletion.
by: Timothy eNacarelli, et al.
Published: (2014-07-01)

The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway
by: Lei Liu, et al.
Published: (2018-10-01)

Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats
by: Dai QD, et al.
Published: (2018-12-01)

Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
by: Cabrera-López Cristina, et al.
Published: (2012-11-01)

INHIBITION OF mTOR KINASE AFFECTS ASTROCYTES GFAP mRNA EXPRESSION IN IN VITRO CONDITIONS
by: Anna Latacz, et al.
Published: (2014-02-01)

Rosemary (Rosmarinus officinalis L.) extract inhibits prostate cancer cell proliferation and survival by targeting Akt and mTOR
by: Alina Jaglanian, et al.
Published: (2020-11-01)

Huge soft tissue PEComa with aggressive lung and bone metastases
by: Shih-Hao Tang, et al.
Published: (2017-09-01)

Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia–Reperfusion With Increased Blood–Brain Barrier Disruption
by: Daniel J. Beard, et al.
Published: (2021-09-01)

Metabolic Regulation of Thymic Epithelial Cell Function
by: Manpreet K. Semwal, et al.
Published: (2021-03-01)

PDK1 Activity Regulates Proliferation, Invasion and Growth of Hemangiomas
by: Ningning Zheng, et al.
Published: (2015-07-01)

Rapamisinin Sıçanlarda Penisilinle Oluşturulmuş Epileptiform Aktivite Üzerine Etkisi: Bir Elektrofizyolojik Çalışma
by: Seyit Ankaralı, et al.
Published: (2016-09-01)

Autophagy induction by endothelial-monocyte activating polypeptide II contributes to the inhibition of malignant biological behaviors by the combination of EMAP II with rapamycin in human glioblastoma
by: Jun eMa, et al.
Published: (2015-12-01)

AKT–THE MAMMALIAN TARGET OF RAPAMYCIN (MTOR) PATHWAY INHIBITION INCREASES CERVICAL CANCER CELL CHEMOSENSITIVITY TO ACTIVE FORM OF IRINOTECAN (SN-38)
by: Leri Septiani, et al.
Published: (2015-07-01)

Cannot write session to /tmp/vufind_sessions/sess_v9jgkvjpjitfn3e0pmudsk6st5